Wikidata entity: Q413581
C₃₂H₄₀BrN₅O₅ (P274)
Quantities
| P4250 | defined daily dose | 40 |
| P2067 | mass | 653.221 |
| P3780 | active ingredient in | ... | Q47521428 (Cycloset) | Cycloset |
| P3780 | active ingredient in | ... | Q47521965 (Parlodel) | Parlodel |
| P233 | canonical SMILES | String | CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O | ??? |
| P373 | Commons category | String | Bromocriptine | ??? |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q879 (bromine) | bromine |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Bromocriptine%20ball-and-stick.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284515 (LiverTox toxicity likelihood category D) | LiverTox toxicity likelihood category D |
| P2175 | medical condition treated | ... | Q11085 (Parkinson's disease) | Parkinson's disease |
| P2175 | medical condition treated | ... | Q334655 (amenorrhea) | amenorrhea |
| P2175 | medical condition treated | ... | Q179399 (infertility) | infertility |
| P2175 | medical condition treated | ... | Q189580 (acromegaly) | acromegaly |
| P2175 | medical condition treated | ... | Q938107 (hypogonadism) | hypogonadism |
| P2175 | medical condition treated | ... | Q954831 (prolactinoma) | prolactinoma |
| P2175 | medical condition treated | ... | Q18556776 (prolactin producing pituitary tumor) | prolactin producing pituitary tumor |
| P2175 | medical condition treated | ... | Q1424956 (neuroleptic malignant syndrome) | neuroleptic malignant syndrome |
| P2175 | medical condition treated | ... | Q1433936 (hyperprolactinemia) | hyperprolactinemia |
| P129 | physically interacts with | ... | Q288797 (5-hydroxytryptamine receptor 1B) | 5-hydroxytryptamine receptor 1B |
| P129 | physically interacts with | ... | Q308856 (Dopamine receptor D4) | Dopamine receptor D4 |
| P129 | physically interacts with | ... | Q4639596 (5-hydroxytryptamine receptor 2B) | 5-hydroxytryptamine receptor 2B |
| P129 | physically interacts with | ... | Q4734891 (Adrenoceptor alpha 2C) | Adrenoceptor alpha 2C |
| P129 | physically interacts with | ... | Q4734892 (Adrenoceptor alpha 2A) | Adrenoceptor alpha 2A |
| P129 | physically interacts with | ... | Q21108118 (5-hydroxytryptamine receptor 2C) | 5-hydroxytryptamine receptor 2C |
| P129 | physically interacts with | ... | Q21109363 (5-hydroxytryptamine receptor 6) | 5-hydroxytryptamine receptor 6 |
| P129 | physically interacts with | ... | Q21110867 (Dopamine receptor D1) | Dopamine receptor D1 |
| P129 | physically interacts with | ... | Q1949517 (5-hydroxytryptamine receptor 2A) | 5-hydroxytryptamine receptor 2A |
| P129 | physically interacts with | ... | Q2034004 (Dopamine receptor D2) | Dopamine receptor D2 |
| P129 | physically interacts with | ... | Q21110872 (Dopamine receptor D3) | Dopamine receptor D3 |
| P129 | physically interacts with | ... | Q21115043 (5-hydroxytryptamine receptor 1A) | 5-hydroxytryptamine receptor 1A |
| P129 | physically interacts with | ... | Q21115046 (5-hydroxytryptamine receptor 1D) | 5-hydroxytryptamine receptor 1D |
| P129 | physically interacts with | ... | Q21131500 (Dopamine receptor D5) | Dopamine receptor D5 |
| P129 | physically interacts with | ... | Q21141045 (Adrenoceptor alpha 2B) | Adrenoceptor alpha 2B |
| P3489 | pregnancy category | ... | Q3679189 (Australian pregnancy category A) | Australian pregnancy category A |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P5555 | schematic | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Bromocriptine%20synthesis.png | ??? |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q58376 (fluphenazine) | fluphenazine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q412443 (risperidone) | risperidone |
| P769 | significant drug interaction | ... | Q412666 (ramipril) | ramipril |
| P769 | significant drug interaction | ... | Q421119 (captopril) | captopril |
| P769 | significant drug interaction | ... | Q422185 (enalapril) | enalapril |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q1078392 (indapamide) | indapamide |
| P769 | significant drug interaction | ... | Q425293 (fosinopril) | fosinopril |
| P769 | significant drug interaction | ... | Q596022 (quinapril) | quinapril |
| P769 | significant drug interaction | ... | Q929420 (trandolapril) | trandolapril |
| P769 | significant drug interaction | ... | Q47495698 (lisinopril dihydrate) | lisinopril dihydrate |
| P3364 | stereoisomer of | ... | Q27166519 (LSM-5805) | LSM-5805 |
| P3364 | stereoisomer of | ... | Q82393823 ((5'alpha,8alpha)-2-Bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman) | (5'alpha,8alpha)-2-Bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P279 | subclass of | ... | Q49873234 (ergoline alkaloid) | ergoline alkaloid |
| P279 | subclass of | ... | Q109476791 (biogenic 2,5-diketopiperazine) | biogenic 2,5-diketopiperazine |
| P2868 | subject has role | ... | Q600203 (dopamine agonist) | dopamine agonist |
| P2868 | subject has role | ... | Q3579672 (antiparkinson) | antiparkinson |
| P2868 | subject has role | ... | Q16875676 (hormone antagonist) | hormone antagonist |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | bromocriptine | ??? |
Why not click here or view trends?
log id: 3149460